首页> Oncotarget> Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage.

Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage.

导出 OA

翻译打印收藏纠错

第一作者： Hyeonseok,Ko

第一单位： Laboratory of Molecular Oncology, Cheil General Hospital & Women's Healthcare Center, College of Medicine, Dankook University, Seoul, South Korea.

作者： Hyeonseok,Ko ^[1] ; Mi-Hyeon,Jeong ^[2] ; Hyelin,Jeon ^[3] ; Gi-Jun,Sung ^[3] ; Youngsin,So ^[3] ; InKi,Kim ^[4] ; JaeKyoung,Son ^[3] ; Sang-wook,Lee ^[5] ; Ho-Geun,Yoon ^[6] ; Kyung-Chul,Choi ^[3]

作者单位： Laboratory of Molecular Oncology, Cheil General Hospital & Women's Healthcare Center, College of Medicine, Dankook University, Seoul, South Korea. ^[1] Department of Biomedical Sciences and Department of Pharmacology, University of Ulsan College of Medicine, Seoul, Korea.;Department of Biochemistry and Molecular Biology, Brain Korea PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea. ^[2] Department of Biomedical Sciences and Department of Pharmacology, University of Ulsan College of Medicine, Seoul, Korea. ^[3] Asan Institute for Medical Research, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. ^[4] Department of Radiation Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. ^[5] Department of Biochemistry and Molecular Biology, Brain Korea PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea. ^[6]

关键词 HDAC3 TRAIL apoptosis delphinidin prostate cancer